SIMILAR PATTERNS OF AMINO ACIDS FOR 4PM5_A_CE3A301_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1alq | CP254 BETA-LACTAMASE (Staphylococcusaureus) |
PF13354(Beta-lactamase2) | 6 | TYR A 105SER A 130ASN A 132ASN A 170LYS A 234GLY A 236 | None | 0.81A | 4pm5A-1alqA:28.0 | 4pm5A-1alqA:30.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1bsg | BETA LACTAMASE (Streptomycesalbus) |
PF13354(Beta-lactamase2) | 7 | ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236GLY A 238 | None | 0.32A | 4pm5A-1bsgA:42.6 | 4pm5A-1bsgA:46.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1bsg | BETA LACTAMASE (Streptomycesalbus) |
PF13354(Beta-lactamase2) | 7 | SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236GLY A 238 | None | 0.61A | 4pm5A-1bsgA:42.6 | 4pm5A-1bsgA:46.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1bue | PROTEIN(IMIPENEM-HYDROLYSING BETA-LACTAMASE) (Enterobactercloacae) |
PF13354(Beta-lactamase2) | 6 | ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236 | None | 0.67A | 4pm5A-1bueA:40.5 | 4pm5A-1bueA:49.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1bue | PROTEIN(IMIPENEM-HYDROLYSING BETA-LACTAMASE) (Enterobactercloacae) |
PF13354(Beta-lactamase2) | 6 | ASN A 170THR A 216LYS A 234THR A 235GLY A 236SER A 237 | None | 0.72A | 4pm5A-1bueA:40.5 | 4pm5A-1bueA:49.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1bue | PROTEIN(IMIPENEM-HYDROLYSING BETA-LACTAMASE) (Enterobactercloacae) |
PF13354(Beta-lactamase2) | 6 | SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236 | None | 0.90A | 4pm5A-1bueA:40.5 | 4pm5A-1bueA:49.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1bue | PROTEIN(IMIPENEM-HYDROLYSING BETA-LACTAMASE) (Enterobactercloacae) |
PF13354(Beta-lactamase2) | 6 | SER A 130ASN A 170LYS A 234THR A 235GLY A 236SER A 237 | None | 0.99A | 4pm5A-1bueA:40.5 | 4pm5A-1bueA:49.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1dy6 | CARBAPENEM-HYDROLYSING BETA-LACTAMASESME-1 (Serratiamarcescens) |
PF13354(Beta-lactamase2) | 6 | ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236 | None | 0.60A | 4pm5A-1dy6A:41.1 | 4pm5A-1dy6A:48.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1dy6 | CARBAPENEM-HYDROLYSING BETA-LACTAMASESME-1 (Serratiamarcescens) |
PF13354(Beta-lactamase2) | 6 | ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 239 | None | 0.90A | 4pm5A-1dy6A:41.1 | 4pm5A-1dy6A:48.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1dy6 | CARBAPENEM-HYDROLYSING BETA-LACTAMASESME-1 (Serratiamarcescens) |
PF13354(Beta-lactamase2) | 6 | ASN A 170THR A 216LYS A 234THR A 235GLY A 236SER A 237 | None | 0.70A | 4pm5A-1dy6A:41.1 | 4pm5A-1dy6A:48.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1dy6 | CARBAPENEM-HYDROLYSING BETA-LACTAMASESME-1 (Serratiamarcescens) |
PF13354(Beta-lactamase2) | 6 | SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236 | None | 0.86A | 4pm5A-1dy6A:41.1 | 4pm5A-1dy6A:48.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1dy6 | CARBAPENEM-HYDROLYSING BETA-LACTAMASESME-1 (Serratiamarcescens) |
PF13354(Beta-lactamase2) | 6 | SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 239 | None | 1.04A | 4pm5A-1dy6A:41.1 | 4pm5A-1dy6A:48.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1dy6 | CARBAPENEM-HYDROLYSING BETA-LACTAMASESME-1 (Serratiamarcescens) |
PF13354(Beta-lactamase2) | 6 | SER A 130ASN A 170LYS A 234THR A 235GLY A 236SER A 237 | None | 0.97A | 4pm5A-1dy6A:41.1 | 4pm5A-1dy6A:48.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1e25 | EXTENDED-SPECTRUMBETA-LACTAMASE PER-1 (Pseudomonasaeruginosa) |
PF13354(Beta-lactamase2) | 6 | SER A 130ASN A 132THR A 216LYS A 234THR A 235GLY A 236 | SO4 A 500 (-2.6A)NoneSO4 A 500 ( 4.0A)SO4 A 500 (-3.2A)SO4 A 500 (-3.8A)SO4 A 500 (-3.5A) | 0.63A | 4pm5A-1e25A:32.5 | 4pm5A-1e25A:29.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1g68 | BETA-LACTAMASE PSE-4 (Pseudomonasaeruginosa) |
PF13354(Beta-lactamase2) | 6 | TYR A 105SER A 130ASN A 132ASN A 170GLY A 236GLY A 238 | NoneSO4 A 400 (-2.7A)NoneNoneSO4 A 400 (-3.0A)None | 0.47A | 4pm5A-1g68A:39.4 | 4pm5A-1g68A:39.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hzo | BETA-LACTAMASE (Proteusvulgaris) |
PF13354(Beta-lactamase2) | 9 | TYR A 105ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236SER A 237GLY A 238 | MES A1000 (-3.9A)NoneNoneMES A1000 (-3.7A)MES A1000 (-2.9A)MES A1000 (-3.7A)MES A1000 (-3.1A)MES A1000 (-2.7A)None | 0.53A | 4pm5A-1hzoA:46.7 | 4pm5A-1hzoA:65.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hzo | BETA-LACTAMASE (Proteusvulgaris) |
PF13354(Beta-lactamase2) | 9 | TYR A 105SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236SER A 237GLY A 238 | MES A1000 (-3.9A)MES A1000 (-2.7A)NoneNoneMES A1000 (-2.9A)MES A1000 (-3.7A)MES A1000 (-3.1A)MES A1000 (-2.7A)None | 0.74A | 4pm5A-1hzoA:46.7 | 4pm5A-1hzoA:65.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1i2w | BETA-LACTAMASE (Bacilluslicheniformis) |
PF13354(Beta-lactamase2) | 8 | ASN A 104TYR A 105ASN A 132THR A 216LYS A 234THR A 235GLY A 236GLY A 238 | CFX A1300 (-3.9A)CFX A1300 ( 4.9A)CFX A1300 (-3.0A)CFX A1300 (-3.2A)CFX A1300 ( 3.9A)CFX A1300 (-3.6A)CFX A1300 (-3.3A)CFX A1300 ( 4.1A) | 0.40A | 4pm5A-1i2wA:41.2 | 4pm5A-1i2wA:42.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1i2w | BETA-LACTAMASE (Bacilluslicheniformis) |
PF13354(Beta-lactamase2) | 8 | ASN A 104TYR A 105SER A 130ASN A 132LYS A 234THR A 235GLY A 236GLY A 238 | CFX A1300 (-3.9A)CFX A1300 ( 4.9A)CFX A1300 (-3.1A)CFX A1300 (-3.0A)CFX A1300 ( 3.9A)CFX A1300 (-3.6A)CFX A1300 (-3.3A)CFX A1300 ( 4.1A) | 0.61A | 4pm5A-1i2wA:41.2 | 4pm5A-1i2wA:42.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1j9m | DD-TRANSPEPTIDASE (Streptomycessp. K15) |
PF00768(Peptidase_S11) | 6 | SER A 96LYS A 213THR A 214GLY A 215SER A 216GLY A 217 | NA A 600 (-3.1A) NA A 600 (-3.4A) NA A 600 (-3.9A) NA A 600 ( 3.6A) CL A 601 (-3.0A)None | 0.61A | 4pm5A-1j9mA:22.0 | 4pm5A-1j9mA:27.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1j9m | DD-TRANSPEPTIDASE (Streptomycessp. K15) |
PF00768(Peptidase_S11) | 6 | THR A 199LYS A 213THR A 214GLY A 215SER A 216GLY A 217 | NA A 600 ( 4.5A) NA A 600 (-3.4A) NA A 600 (-3.9A) NA A 600 ( 3.6A) CL A 601 (-3.0A)None | 0.30A | 4pm5A-1j9mA:22.0 | 4pm5A-1j9mA:27.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1n4o | L2 BETA-LACTAMASE (Stenotrophomonasmaltophilia) |
PF13354(Beta-lactamase2) | 8 | SER A 130ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236SER A 237 | SO4 A1002 (-3.1A)NoneNoneSO4 A1002 ( 4.8A)SO4 A1002 (-3.6A)SO4 A1002 (-3.6A)SO4 A1002 (-3.2A)SO4 A1002 (-2.7A) | 0.61A | 4pm5A-1n4oA:40.4 | 4pm5A-1n4oA:47.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) |
PF13354(Beta-lactamase2) | 7 | TYR A 105SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236 | EPE A 400 (-3.6A)EPE A 400 (-2.5A)NoneNoneEPE A 400 (-3.1A)EPE A 400 (-3.8A)EPE A 400 (-3.1A) | 0.42A | 4pm5A-1n9bA:35.6 | 4pm5A-1n9bA:39.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1w5d | PENICILLIN-BINDINGPROTEIN (Bacillussubtilis) |
PF02113(Peptidase_S13) | 5 | ASN A 301THR A 394LYS A 411THR A 412GLY A 413 | None | 0.31A | 4pm5A-1w5dA:21.0 | 4pm5A-1w5dA:22.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1zg4 | BETA-LACTAMASE TEM (Escherichiacoli) |
PF13354(Beta-lactamase2) | 7 | TYR A 105SER A 130ASN A 132ASN A 170LYS A 234GLY A 236GLY A 238 | None | 0.72A | 4pm5A-1zg4A:38.3 | 4pm5A-1zg4A:38.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2c6w | PENICILLIN-BINDINGPROTEIN 1A (Streptococcuspneumoniae) |
PF00905(Transpeptidase) | 6 | SER B 428ASN B 430THR B 543LYS B 557THR B 558GLY B 559 | CL B 704 (-3.4A)None CL B 704 ( 4.8A)None CL B 704 (-4.5A) CL B 704 ( 4.0A) | 0.69A | 4pm5A-2c6wB:17.0 | 4pm5A-2c6wB:22.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2cc1 | BETA-LACTAMASE (Mycolicibacteriumfortuitum) |
PF13354(Beta-lactamase2) | 6 | SER A 130ASN A 105THR A 235GLY A 236SER A 237GLY A 238 | None | 1.45A | 4pm5A-2cc1A:40.7 | 4pm5A-2cc1A:44.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2cc1 | BETA-LACTAMASE (Mycolicibacteriumfortuitum) |
PF13354(Beta-lactamase2) | 8 | SER A 130ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236GLY A 238 | None | 0.56A | 4pm5A-2cc1A:40.7 | 4pm5A-2cc1A:44.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2cc1 | BETA-LACTAMASE (Mycolicibacteriumfortuitum) |
PF13354(Beta-lactamase2) | 8 | SER A 130ASN A 170THR A 216LYS A 234THR A 235GLY A 236SER A 237GLY A 238 | None | 0.72A | 4pm5A-2cc1A:40.7 | 4pm5A-2cc1A:44.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fff | PENICILLIN-BINDINGPROTEIN 1B (Streptococcuspneumoniae) |
PF00905(Transpeptidase) | 6 | TYR B 498ASN B 518THR B 629LYS B 651THR B 652GLY B 653 | None | 0.60A | 4pm5A-2fffB:17.0 | 4pm5A-2fffB:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fff | PENICILLIN-BINDINGPROTEIN 1B (Streptococcuspneumoniae) |
PF00905(Transpeptidase) | 6 | TYR B 498SER B 516ASN B 518LYS B 651THR B 652GLY B 653 | None | 0.74A | 4pm5A-2fffB:17.0 | 4pm5A-2fffB:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2iwb | METHICILLINRESISTANCE MECR1PROTEIN (Staphylococcusaureus) |
PF00905(Transpeptidase) | 6 | SER A 439ASN A 441LYS A 528THR A 529GLY A 530GLY A 532 | GOL A 604 (-2.6A)GOL A 605 (-2.8A)GOL A 604 (-2.9A)GOL A 604 (-3.7A)GOL A 605 ( 3.2A)None | 0.64A | 4pm5A-2iwbA:19.4 | 4pm5A-2iwbA:22.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jch | PENICILLIN-BINDINGPROTEIN 1B (Streptococcuspneumoniae) |
PF00905(Transpeptidase)PF00912(Transgly) | 7 | TYR A 498SER A 516ASN A 518THR A 629LYS A 651THR A 652GLY A 653 | PL7 A1793 (-4.3A)PL7 A1793 (-3.0A)PL7 A1793 (-3.2A)PL7 A1793 ( 4.1A)PL7 A1793 ( 4.1A)PL7 A1793 (-3.9A)PL7 A1793 (-3.3A) | 0.83A | 4pm5A-2jchA:15.5 | 4pm5A-2jchA:17.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rdl | CHYMASE 2 (Mesocricetusauratus) |
PF00089(Trypsin) | 6 | GLY A 197ASN A 189THR A 229GLY A 196SER A 195GLY A 193 | None | 1.46A | 4pm5A-2rdlA:undetectable | 4pm5A-2rdlA:25.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2v2f | PENICILLIN BINDINGPROTEIN 1A (Streptococcuspneumoniae) |
PF00905(Transpeptidase) | 6 | SER F 428ASN F 430THR F 543LYS F 557THR F 558GLY F 559 | MES F1653 (-3.1A)NoneMES F1653 (-3.7A)MES F1653 ( 4.0A)MES F1653 (-3.8A)MES F1653 (-3.6A) | 0.65A | 4pm5A-2v2fF:17.9 | 4pm5A-2v2fF:24.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wae | PENICILLIN-BINDINGPROTEIN 2B (Streptococcuspneumoniae) |
PF00905(Transpeptidase)PF03717(PBP_dimer) | 6 | SER A 443ASN A 445THR A 600LYS A 615THR A 616GLY A 617 | None | 0.66A | 4pm5A-2waeA:16.0 | 4pm5A-2waeA:17.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2wyx | BETA-LACTAMSE TOHO-1 (Escherichiacoli) |
PF13354(Beta-lactamase2) | 10 | ASN A 104TYR A 105ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236SER A 237GLY A 238 | None | 0.48A | 4pm5A-2wyxA:46.0 | 4pm5A-2wyxA:83.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2wyx | BETA-LACTAMSE TOHO-1 (Escherichiacoli) |
PF13354(Beta-lactamase2) | 9 | ASN A 104TYR A 105SER A 130ASN A 132LYS A 234THR A 235GLY A 236SER A 237GLY A 238 | None | 0.68A | 4pm5A-2wyxA:46.0 | 4pm5A-2wyxA:83.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2wyx | BETA-LACTAMSE TOHO-1 (Escherichiacoli) |
PF13354(Beta-lactamase2) | 7 | GLY A 236ASN A 104TYR A 105ASN A 170THR A 216LYS A 234GLY A 238 | None | 1.44A | 4pm5A-2wyxA:46.0 | 4pm5A-2wyxA:83.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3a3i | PENICILLIN-BINDINGPROTEIN 4 (Haemophilusinfluenzae) |
PF02113(Peptidase_S13) | 6 | ASN A 312THR A 401LYS A 420THR A 421GLY A 422SER A 423 | AIX A 501 (-3.3A)AIX A 501 ( 4.0A)AIX A 501 ( 3.8A)AIX A 501 (-3.4A)AIX A 501 (-3.4A)AIX A 501 (-2.5A) | 0.70A | 4pm5A-3a3iA:20.6 | 4pm5A-3a3iA:21.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3a3i | PENICILLIN-BINDINGPROTEIN 4 (Haemophilusinfluenzae) |
PF02113(Peptidase_S13) | 6 | SER A 310ASN A 312LYS A 420THR A 421GLY A 422SER A 423 | AIX A 501 (-2.8A)AIX A 501 (-3.3A)AIX A 501 ( 3.8A)AIX A 501 (-3.4A)AIX A 501 (-3.4A)AIX A 501 (-2.5A) | 0.91A | 4pm5A-3a3iA:20.6 | 4pm5A-3a3iA:21.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) |
PF13354(Beta-lactamase2) | 7 | ASN A 104ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236 | MER A 301 ( 4.1A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A) | 0.43A | 4pm5A-3bfgA:46.9 | 4pm5A-3bfgA:75.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3bfg | CLASS ABETA-LACTAMASE SED1 (Citrobactersedlakii) |
PF13354(Beta-lactamase2) | 7 | ASN A 104SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236 | MER A 301 ( 4.1A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-2.6A)MER A 301 (-3.2A)MER A 301 (-3.5A)MER A 301 (-3.0A) | 0.66A | 4pm5A-3bfgA:46.9 | 4pm5A-3bfgA:75.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3byd | BETA-LACTAMASE OXY-1 (Klebsiellaoxytoca) |
PF13354(Beta-lactamase2) | 7 | ASN A 135ASN A 173THR A 219LYS A 237THR A 238GLY A 239GLY A 241 | NoneNoneSO4 A 301 ( 4.0A)SO4 A 301 (-3.1A)SO4 A 301 (-3.9A)SO4 A 301 (-3.3A)None | 0.29A | 4pm5A-3bydA:47.3 | 4pm5A-3bydA:74.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3byd | BETA-LACTAMASE OXY-1 (Klebsiellaoxytoca) |
PF13354(Beta-lactamase2) | 7 | SER A 133ASN A 135ASN A 173LYS A 237THR A 238GLY A 239GLY A 241 | SO4 A 301 (-2.8A)NoneNoneSO4 A 301 (-3.1A)SO4 A 301 (-3.9A)SO4 A 301 (-3.3A)None | 0.61A | 4pm5A-3bydA:47.3 | 4pm5A-3bydA:74.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dwk | PENICILLIN-BINDINGPROTEIN 2 (Staphylococcusaureus) |
PF00905(Transpeptidase)PF00912(Transgly) | 6 | SER A 454ASN A 456LYS A 583THR A 584GLY A 585GLY A 587 | SO4 A 26 (-3.1A)NoneSO4 A 26 ( 4.2A)SO4 A 26 (-3.6A)SO4 A 26 (-3.3A)None | 0.81A | 4pm5A-3dwkA:18.3 | 4pm5A-3dwkA:18.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) |
PF13354(Beta-lactamase2) | 6 | ASN A 186THR A 232LYS A 250THR A 251GLY A 252GLY A 254 | DWZ A 400 ( 4.0A)DWZ A 400 ( 4.5A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)None | 0.34A | 4pm5A-3dwzA:41.1 | 4pm5A-3dwzA:45.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3dwz | BETA-LACTAMASE (Mycobacteriumtuberculosis) |
PF13354(Beta-lactamase2) | 6 | SER A 142ASN A 186LYS A 250THR A 251GLY A 252GLY A 254 | DWZ A 400 (-2.7A)DWZ A 400 ( 4.0A)DWZ A 400 ( 3.8A)DWZ A 400 (-3.5A)DWZ A 400 (-3.3A)None | 0.62A | 4pm5A-3dwzA:41.1 | 4pm5A-3dwzA:45.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lez | BETA-LACTAMASE (Oceanobacillusiheyensis) |
PF13354(Beta-lactamase2) | 9 | TYR A 118SER A 143ASN A 145ASN A 183THR A 229LYS A 247THR A 248GLY A 249GLY A 251 | EPE A 305 (-3.3A)EPE A 305 (-2.5A)NoneNoneEPE A 305 ( 3.9A)EPE A 305 (-3.1A)EPE A 305 (-3.6A)EPE A 305 (-3.4A)None | 0.37A | 4pm5A-3lezA:41.4 | 4pm5A-3lezA:43.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3p09 | BETA-LACTAMASE (Francisellatularensis) |
PF13354(Beta-lactamase2) | 7 | TYR A 98SER A 122ASN A 162THR A 208LYS A 226THR A 227GLY A 228 | NoneSO4 A 288 (-2.7A)NoneSO4 A 288 ( 4.8A)SO4 A 288 (-3.5A)SO4 A 288 (-3.6A)SO4 A 288 (-3.3A) | 0.92A | 4pm5A-3p09A:39.4 | 4pm5A-3p09A:30.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3q7z | BETA-LACTAMASEREGULATORY PROTEINBLAR1 (Staphylococcusaureus) |
PF00905(Transpeptidase) | 6 | SER A 437ASN A 439LYS A 526THR A 527GLY A 528GLY A 530 | BOU A 584 (-2.8A)BOU A 584 (-3.5A)BOU A 584 (-3.3A)BOU A 584 (-3.6A)BOU A 584 (-3.7A)BOU A 584 ( 3.9A) | 0.64A | 4pm5A-3q7zA:18.0 | 4pm5A-3q7zA:20.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3qhy | BETA-LACTAMASE (Bacillusanthracis) |
PF13354(Beta-lactamase2) | 6 | ASN A 132ASN A 170THR A 216LYS A 234GLY A 236GLY A 238 | None | 0.45A | 4pm5A-3qhyA:41.8 | 4pm5A-3qhyA:43.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3qhy | BETA-LACTAMASE (Bacillusanthracis) |
PF13354(Beta-lactamase2) | 6 | SER A 130ASN A 132ASN A 170LYS A 234GLY A 236GLY A 238 | None | 0.64A | 4pm5A-3qhyA:41.8 | 4pm5A-3qhyA:43.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3v39 | D-ALANYL-D-ALANINECARBOXYPEPTIDASE (Bdellovibriobacteriovorus) |
PF02113(Peptidase_S13) | 5 | ASN A 253THR A 342LYS A 357THR A 358GLY A 359 | TAU A 501 (-3.1A)NoneTAU A 501 ( 4.3A)NoneTAU A 501 (-3.5A) | 0.31A | 4pm5A-3v39A:17.7 | 4pm5A-3v39A:20.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vsk | PENICILLIN-BINDINGPROTEIN 3 (Staphylococcusaureus) |
PF00905(Transpeptidase)PF03717(PBP_dimer) | 6 | SER A 448ASN A 450THR A 603LYS A 618THR A 619GLY A 620 | None | 0.76A | 4pm5A-3vskA:16.8 | 4pm5A-3vskA:19.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3w4q | BETA-LACTAMASE (Burkholderiamultivorans) |
PF13354(Beta-lactamase2) | 8 | TYR A 105SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236GLY A 238 | None | 0.65A | 4pm5A-3w4qA:44.0 | 4pm5A-3w4qA:57.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3zdj | ENCA BETA-LACTAMASE (syntheticconstruct) |
PF13354(Beta-lactamase2) | 8 | TYR A 105SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236GLY A 238 | NoneSO4 A1291 (-3.1A)NoneNoneSO4 A1291 (-3.3A)SO4 A1291 (-3.6A)SO4 A1291 (-3.3A)None | 0.68A | 4pm5A-3zdjA:38.6 | 4pm5A-3zdjA:43.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zg8 | PENICILLIN-BINDINGPROTEIN 4 (Listeriamonocytogenes) |
PF00905(Transpeptidase)PF00912(Transgly) | 7 | SER B 449ASN B 451THR B 561LYS B 575THR B 576GLY B 577SER B 578 | AIX B 800 (-2.4A)AIX B 800 (-2.7A)AIX B 800 ( 3.8A)AIX B 800 ( 4.0A)AIX B 800 (-3.4A)AIX B 800 ( 3.7A)AIX B 800 (-3.0A) | 0.72A | 4pm5A-3zg8B:17.5 | 4pm5A-3zg8B:19.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3zny | CTX-M-12A ENZYME (Klebsiellapneumoniae) |
PF13354(Beta-lactamase2) | 9 | TYR A 105ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236SER A 237GLY A 238 | None | 0.42A | 4pm5A-3znyA:47.3 | 4pm5A-3znyA:82.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3zny | CTX-M-12A ENZYME (Klebsiellapneumoniae) |
PF13354(Beta-lactamase2) | 9 | TYR A 105SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236SER A 237GLY A 238 | None | 0.61A | 4pm5A-3znyA:47.3 | 4pm5A-3znyA:82.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zvt | D-ALANYL-D-ALANINECARBOXYPEPTIDASE (Actinomadurasp. R39) |
PF02113(Peptidase_S13) | 5 | ASN A 300THR A 393LYS A 410THR A 411GLY A 412 | B07 A 500 ( 4.2A)B07 A 500 ( 4.8A)B07 A 500 (-1.6A)B07 A 500 (-4.8A)B07 A 500 (-3.2A) | 0.26A | 4pm5A-3zvtA:20.9 | 4pm5A-3zvtA:22.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4c6y | BETA-LACTAMASE (syntheticconstruct) |
PF13354(Beta-lactamase2) | 8 | SER A 130ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236GLY A 238 | PEG A 307 (-2.4A)PEG A 307 (-3.1A)PEG A 307 ( 4.3A)PEG A 307 ( 4.3A)PEG A 307 ( 3.4A)PEG A 307 (-3.0A)PEG A 307 (-2.7A)None | 0.56A | 4pm5A-4c6yA:43.4 | 4pm5A-4c6yA:58.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4c6y | BETA-LACTAMASE (syntheticconstruct) |
PF13354(Beta-lactamase2) | 7 | TYR A 105SER A 130ASN A 132THR A 216LYS A 234THR A 235GLY A 238 | PEG A 307 ( 3.2A)PEG A 307 (-2.4A)PEG A 307 (-3.1A)PEG A 307 ( 4.3A)PEG A 307 ( 3.4A)PEG A 307 (-3.0A)None | 0.82A | 4pm5A-4c6yA:43.4 | 4pm5A-4c6yA:58.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4c75 | BETA-LACTAMASE (syntheticconstruct) |
PF13354(Beta-lactamase2) | 9 | TYR A 105SER A 130ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236GLY A 238 | NoneSO4 A 291 (-2.8A)NoneNoneSO4 A 291 ( 4.1A)SO4 A 291 (-3.4A)SO4 A 291 (-3.8A) NA A 294 ( 3.2A)None | 0.65A | 4pm5A-4c75A:42.7 | 4pm5A-4c75A:57.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4d2o | PER-2 BETA-LACTAMASE (Citrobacterfreundii) |
PF13354(Beta-lactamase2) | 6 | SER A 130ASN A 132THR A 216LYS A 234THR A 235GLY A 236 | None | 0.49A | 4pm5A-4d2oA:32.3 | 4pm5A-4d2oA:31.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) |
PF13354(Beta-lactamase2) | 6 | ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236 | MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 ( 3.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A) | 0.46A | 4pm5A-4ev4A:42.1 | 4pm5A-4ev4A:48.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) |
PF13354(Beta-lactamase2) | 6 | SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236 | MER A 401 (-2.8A)MER A 401 (-3.2A)MER A 401 (-2.9A)MER A 401 (-3.0A)MER A 401 (-3.5A)MER A 401 (-3.6A) | 0.75A | 4pm5A-4ev4A:42.1 | 4pm5A-4ev4A:48.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mnr | PEPTIDOGLYCANGLYCOSYLTRANSFERASE (Eggerthellalenta) |
PF00905(Transpeptidase) | 6 | SER A 237ASN A 239THR A 383LYS A 397THR A 398GLY A 399 | None | 0.62A | 4pm5A-4mnrA:17.6 | 4pm5A-4mnrA:23.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oon | PENICILLIN-BINDINGPROTEIN 1A (Pseudomonasaeruginosa) |
PF00905(Transpeptidase)PF00912(Transgly)PF17092(PCB_OB) | 6 | SER A 520ASN A 522THR A 680LYS A 695THR A 696GLY A 697 | 2U4 A 901 (-3.6A)2U4 A 901 (-2.9A)2U4 A 901 (-4.1A)2U4 A 901 ( 4.3A)2U4 A 901 (-3.7A)2U4 A 901 (-3.7A) | 0.80A | 4pm5A-4oonA:16.9 | 4pm5A-4oonA:16.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ovd | PEPTIDOGLYCANGLYCOSYLTRANSFERASE (Atopobiumparvulum) |
PF00905(Transpeptidase)PF03717(PBP_dimer) | 6 | ASN A 363THR A 486LYS A 500THR A 501GLY A 502GLY A 504 | None CA A 601 ( 4.7A) CA A 601 ( 4.1A) CA A 601 (-4.0A) CA A 601 ( 4.2A)None | 0.77A | 4pm5A-4ovdA:17.7 | 4pm5A-4ovdA:21.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ovd | PEPTIDOGLYCANGLYCOSYLTRANSFERASE (Atopobiumparvulum) |
PF00905(Transpeptidase)PF03717(PBP_dimer) | 6 | SER A 361ASN A 363LYS A 500THR A 501GLY A 502GLY A 504 | CA A 601 ( 3.8A)None CA A 601 ( 4.1A) CA A 601 (-4.0A) CA A 601 ( 4.2A)None | 0.92A | 4pm5A-4ovdA:17.7 | 4pm5A-4ovdA:21.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ra7 | PEPTIDOGLYCANGLYCOSYLTRANSFERASE (Atopobiumparvulum) |
PF00905(Transpeptidase) | 6 | SER A 737ASN A 739THR A 876LYS A 890THR A 891GLY A 892 | NXU A1001 (-3.2A)NXU A1001 (-3.5A)NXU A1001 (-4.0A)NXU A1001 (-3.5A)NXU A1001 (-3.3A)NXU A1001 (-3.4A) | 0.62A | 4pm5A-4ra7A:16.9 | 4pm5A-4ra7A:22.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4yfm | BETA-LACTAMASE (Mycobacteroidesabscessus) |
PF13354(Beta-lactamase2) | 8 | SER A 131ASN A 133ASN A 171THR A 215LYS A 233THR A 234GLY A 235GLY A 237 | ACT A 301 (-2.9A)NoneNoneACT A 301 (-3.7A)ACT A 301 (-3.4A)ACT A 301 (-3.5A)ACT A 301 (-3.3A)None | 0.61A | 4pm5A-4yfmA:41.8 | 4pm5A-4yfmA:44.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ztk | CELL DIVISIONPROTEINFTSI/PENICILLINBINDING PROTEIN 2 (Legionellapneumophila) |
PF00905(Transpeptidase) | 6 | SER A 454ASN A 456THR A 554LYS A 568THR A 569GLY A 570 | NHE A 901 (-2.9A)NoneNHE A 901 ( 4.2A)NHE A 901 (-3.0A)NHE A 901 (-3.6A)NHE A 901 (-3.6A) | 0.66A | 4pm5A-4ztkA:16.8 | 4pm5A-4ztkA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5aqa | OFF7_DB04V3 (syntheticconstruct) |
PF00023(Ank)PF12796(Ank_2)PF13354(Beta-lactamase2) | 6 | SER A 260ASN A 262ASN A 300LYS A 364GLY A 366GLY A 368 | None | 0.74A | 4pm5A-5aqaA:37.5 | 4pm5A-5aqaA:26.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cer | BD0816 (Bdellovibriobacteriovorus) |
PF02113(Peptidase_S13) | 5 | ASN A 241THR A 330LYS A 345THR A 346GLY A 347 | None | 0.29A | 4pm5A-5cerA:18.3 | 4pm5A-5cerA:20.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ctm | BETA-LACTAMASE (Bacilluspumilus) |
PF00905(Transpeptidase) | 6 | SER A 149LYS A 239THR A 240GLY A 241SER A 242GLY A 243 | FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.8A)FLC A 301 (-3.2A)FLC A 301 (-2.8A)None | 0.59A | 4pm5A-5ctmA:18.7 | 4pm5A-5ctmA:22.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5e2e | BETA-LACTAMASE (Yersiniaenterocolitica) |
PF13354(Beta-lactamase2) | 9 | TYR A 82ASN A 109ASN A 147THR A 193LYS A 211THR A 212GLY A 213SER A 214GLY A 215 | None | 0.52A | 4pm5A-5e2eA:44.3 | 4pm5A-5e2eA:58.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5e2e | BETA-LACTAMASE (Yersiniaenterocolitica) |
PF13354(Beta-lactamase2) | 9 | TYR A 82SER A 107ASN A 109ASN A 147LYS A 211THR A 212GLY A 213SER A 214GLY A 215 | None | 0.70A | 4pm5A-5e2eA:44.3 | 4pm5A-5e2eA:58.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5e31 | PENICILLIN BINDINGPROTEIN 2 PRIME (Enterococcusfaecium) |
PF00905(Transpeptidase)PF03717(PBP_dimer)PF05223(MecA_N) | 6 | SER A 480ASN A 482THR A 603LYS A 617THR A 618GLY A 619 | None | 0.67A | 4pm5A-5e31A:17.0 | 4pm5A-5e31A:17.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5e43 | BETA-LACTAMASE (Streptosporangiumroseum) |
PF13354(Beta-lactamase2) | 7 | SER A 131ASN A 133ASN A 171THR A 217LYS A 235THR A 236GLY A 237 | ACT A 311 (-3.0A)NoneNoneACT A 311 ( 3.9A)ACT A 311 (-3.3A)ACT A 311 (-3.7A)ACT A 311 (-3.2A) | 0.59A | 4pm5A-5e43A:42.7 | 4pm5A-5e43A:41.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5eoe | BETA-LACTAMASE (Pseudomonasaeruginosa) |
PF13354(Beta-lactamase2) | 6 | THR A 209LYS A 227THR A 228GLY A 229SER A 230GLY A 235 | CIT A 303 (-3.2A)CIT A 303 (-3.5A)CIT A 303 (-3.6A)CIT A 303 (-3.5A)CIT A 303 (-2.5A)None | 1.23A | 4pm5A-5eoeA:40.7 | 4pm5A-5eoeA:41.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5eoe | BETA-LACTAMASE (Pseudomonasaeruginosa) |
PF13354(Beta-lactamase2) | 8 | TYR A 97ASN A 125ASN A 163THR A 209LYS A 227THR A 228GLY A 229SER A 230 | CIT A 303 (-4.1A)CIT A 303 (-3.2A)NoneCIT A 303 (-3.2A)CIT A 303 (-3.5A)CIT A 303 (-3.6A)CIT A 303 (-3.5A)CIT A 303 (-2.5A) | 0.52A | 4pm5A-5eoeA:40.7 | 4pm5A-5eoeA:41.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5eoe | BETA-LACTAMASE (Pseudomonasaeruginosa) |
PF13354(Beta-lactamase2) | 8 | TYR A 97SER A 123ASN A 125ASN A 163LYS A 227THR A 228GLY A 229SER A 230 | CIT A 303 (-4.1A)CIT A 303 (-2.5A)CIT A 303 (-3.2A)NoneCIT A 303 (-3.5A)CIT A 303 (-3.6A)CIT A 303 (-3.5A)CIT A 303 (-2.5A) | 0.71A | 4pm5A-5eoeA:40.7 | 4pm5A-5eoeA:41.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) |
PF13354(Beta-lactamase2) | 5 | ASN A 127THR A 211LYS A 229THR A 230GLY A 231 | IM2 A 301 (-3.2A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A) | 0.21A | 4pm5A-5f83A:39.4 | 4pm5A-5f83A:37.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5gl9 | BETA-LACTAMASE (Burkholderiathailandensis) |
PF13354(Beta-lactamase2) | 8 | SER A 130ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236GLY A 238 | None | 0.55A | 4pm5A-5gl9A:45.0 | 4pm5A-5gl9A:57.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5gl9 | BETA-LACTAMASE (Burkholderiathailandensis) |
PF13354(Beta-lactamase2) | 7 | TYR A 105SER A 130ASN A 132ASN A 170THR A 216LYS A 234THR A 235 | None | 0.86A | 4pm5A-5gl9A:45.0 | 4pm5A-5gl9A:57.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hlb | PENICILLIN-BINDINGPROTEIN 1B (Escherichiacoli) |
PF00905(Transpeptidase)PF00912(Transgly)PF14814(UB2H) | 6 | SER A 572ASN A 574THR A 682LYS A 698THR A 699GLY A 700 | AZR A 902 ( 3.7A)AZR A 902 (-3.4A)AZR A 902 (-3.4A)AZR A 902 ( 4.5A)AZR A 902 (-3.5A)AZR A 902 (-3.3A) | 0.77A | 4pm5A-5hlbA:18.5 | 4pm5A-5hlbA:18.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5hx9 | BETA-LACTAMASE (Burkholderiavietnamiensis) |
PF13354(Beta-lactamase2) | 5 | GLY A 70ASN A 170LYS A 234GLY A 236GLY A 238 | EDO A 303 (-3.6A)NoneEDO A 303 (-2.6A)NoneNone | 0.22A | 4pm5A-5hx9A:41.4 | 4pm5A-5hx9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ihv | BETA-LACTAMASE (Burkholderiaambifaria) |
PF13354(Beta-lactamase2) | 5 | GLY A 47ASN A 147LYS A 211GLY A 213GLY A 215 | EDO A 302 (-3.6A)NoneEDO A 302 (-2.8A)NoneNone | 0.22A | 4pm5A-5ihvA:41.9 | 4pm5A-5ihvA:49.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ll7 | BETA-LACTAMASE (Escherichiacoli) |
no annotation | 7 | SER A 130ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236 | 6YV A 301 (-2.6A)6YV A 301 (-3.7A)6YV A 301 (-2.9A)6YV A 301 ( 4.2A)6YV A 301 (-3.6A)6YV A 301 (-3.6A)6YV A 301 ( 4.0A) | 0.65A | 4pm5A-5ll7A:43.1 | 4pm5A-5ll7A:16.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ll7 | BETA-LACTAMASE (Escherichiacoli) |
no annotation | 6 | SER A 130THR A 216LYS A 234THR A 235GLY A 236GLY A 239 | 6YV A 301 (-2.6A)6YV A 301 ( 4.2A)6YV A 301 (-3.6A)6YV A 301 (-3.6A)6YV A 301 ( 4.0A)None | 0.88A | 4pm5A-5ll7A:43.1 | 4pm5A-5ll7A:16.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tfq | BETA-LACTAMASE (Bacteroidescellulosilyticus) |
PF13354(Beta-lactamase2) | 8 | TYR A 85SER A 112ASN A 114THR A 197LYS A 215THR A 216GLY A 217SER A 218 | NonePO4 A 301 (-2.6A)NonePO4 A 301 ( 3.8A)PO4 A 301 (-3.2A)PO4 A 301 ( 3.6A)PO4 A 301 (-3.3A)PO4 A 301 (-2.7A) | 0.61A | 4pm5A-5tfqA:33.0 | 4pm5A-5tfqA:26.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5u2g | PENICILLIN-BINDINGPROTEIN 1A (Haemophilusinfluenzae) |
PF00905(Transpeptidase)PF00912(Transgly)PF17092(PCB_OB) | 6 | SER A 510ASN A 512THR A 712LYS A 728THR A 729GLY A 730 | NoneNoneNoneNone CL A 910 ( 4.2A)None | 0.79A | 4pm5A-5u2gA:17.8 | 4pm5A-5u2gA:15.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5vpq | BETA-LACTAMASE (Paraburkholderiaphymatum) |
PF13354(Beta-lactamase2) | 7 | ASN A 121ASN A 159THR A 206THR A 226GLY A 227SER A 228GLY A 229 | NoneNoneNoneNoneNoneEDO A 304 ( 4.8A)EDO A 304 (-3.4A) | 0.71A | 4pm5A-5vpqA:41.4 | 4pm5A-5vpqA:48.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5vpq | BETA-LACTAMASE (Paraburkholderiaphymatum) |
PF13354(Beta-lactamase2) | 6 | SER A 119THR A 206THR A 226GLY A 227SER A 228GLY A 229 | NoneNoneNoneNoneEDO A 304 ( 4.8A)EDO A 304 (-3.4A) | 0.75A | 4pm5A-5vpqA:41.4 | 4pm5A-5vpqA:48.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x5g | BETA-LACTAMASE (Serratiamarcescens) |
PF13354(Beta-lactamase2) | 7 | SER A 120ASN A 122THR A 206LYS A 224THR A 225GLY A 226SER A 227 | OP0 A 305 (-2.7A)OP0 A 305 (-3.1A)OP0 A 305 (-3.6A)OP0 A 305 (-3.4A)OP0 A 305 (-3.7A)OP0 A 305 (-3.2A)OP0 A 305 (-2.4A) | 0.73A | 4pm5A-5x5gA:34.5 | 4pm5A-5x5gA:26.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5zqe | - (-) |
no annotation | 5 | ASN A 120THR A 208LYS A 222THR A 223GLY A 224 | CES A 301 (-3.3A)CES A 301 (-4.3A)NoneCES A 301 (-3.6A)CES A 301 (-3.2A) | 0.27A | 4pm5A-5zqeA:22.1 | 4pm5A-5zqeA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6azi | D-ALANYL-D-ALANINEENDOPEPTIDASE (Enterobactercloacae) |
PF00768(Peptidase_S11) | 5 | ASN A 127THR A 217LYS A 232THR A 233GLY A 234 | SEE A 68 ( 3.6A)NoneSEE A 68 ( 3.5A)NoneSEE A 68 ( 3.9A) | 0.32A | 4pm5A-6aziA:21.4 | 4pm5A-6aziA:27.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6bu3 | BETA-LACTAMASE (Escherichiacoli) |
no annotation | 11 | ASN A 104TYR A 105SER A 130ASN A 132ASN A 170THR A 216LYS A 234THR A 235GLY A 236SER A 237GLY A 238 | 3GK A 301 ( 3.2A)3GK A 302 ( 3.5A)3GK A 301 (-2.7A)3GK A 301 (-3.5A)3GK A 301 (-3.9A)3GK A 302 ( 4.3A)3GK A 301 ( 4.1A)3GK A 301 (-3.7A)3GK A 301 (-3.4A)3GK A 301 ( 2.7A)3GK A 301 (-3.6A) | 0.46A | 4pm5A-6bu3A:48.6 | 4pm5A-6bu3A:97.50 |